Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124325572 | 12432557 | 2 | F | 2008 | 20160627 | 20160603 | 20160705 | PER | US-ASTRAZENECA-2012SE18842 | ASTRAZENECA | 59.00 | YR | M | Y | 112.50000 | KG | 20160705 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124325572 | 12432557 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | TABLET | ||||||||
| 124325572 | 12432557 | 2 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 0 | 20 | MG | QD | |||||||||
| 124325572 | 12432557 | 3 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 124325572 | 12432557 | 4 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | TABLET | QD | |||||||
| 124325572 | 12432557 | 5 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0 | 2 | MG | TABLET | TID | |||||||
| 124325572 | 12432557 | 6 | C | LUNESTA | ESZOPICLONE | 1 | Oral | 0 | 3 | MG | TABLET | QD | |||||||
| 124325572 | 12432557 | 7 | C | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | 150 | MG | BID | |||||||||
| 124325572 | 12432557 | 8 | C | PHENYTOIN. | PHENYTOIN | 1 | 0 | 100 | MG | QD | |||||||||
| 124325572 | 12432557 | 9 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
| 124325572 | 12432557 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | 20 | MG | TABLET | QD | ||||||||
| 124325572 | 12432557 | 11 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 0 | 45 | MG | TABLET | QD | |||||||
| 124325572 | 12432557 | 12 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124325572 | 12432557 | 1 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124325572 | 12432557 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124325572 | 12432557 | Hypertension | |
| 124325572 | 12432557 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124325572 | 12432557 | 1 | 200801 | 0 |